Skip to main content

OptimizeRx Corp 8-K, filed Nov 13, 2026

OptimizeRx Corp (OPRX)

8-K 2026-11-13 For: 2026-11-11
View Original
Added on November 14, 2026

About this 8-K

OptimizeRx Corp filed this 8-K on November 13, 2026, reporting on events of November 11, 2026.

OptimizeRx reported Q3 2026 revenue of $21.6 million, down 17%, and adjusted EBITDA of $6.3 million; it updated 2026 revenue guidance to $87-$93 million while keeping adjusted EBITDA guidance at $21-$25 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits